Tudor Investment Corp’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-79,648
| Closed | -$584K | – | 2042 |
|
2025
Q1 | $584K | Buy |
+79,648
| New | +$584K | ﹤0.01% | 1183 |
|
2024
Q2 | – | Sell |
-74,531
| Closed | -$678K | – | 1832 |
|
2024
Q1 | $678K | Sell |
74,531
-64,200
| -46% | -$584K | ﹤0.01% | 1016 |
|
2023
Q4 | $619K | Sell |
138,731
-35,436
| -20% | -$158K | 0.01% | 1076 |
|
2023
Q3 | $547K | Sell |
174,167
-26,676
| -13% | -$83.8K | 0.01% | 1096 |
|
2023
Q2 | $1.04M | Buy |
200,843
+132,459
| +194% | +$683K | 0.01% | 894 |
|
2023
Q1 | $360K | Sell |
68,384
-30,954
| -31% | -$163K | 0.01% | 1225 |
|
2022
Q4 | $279K | Buy |
99,338
+37,563
| +61% | +$105K | 0.01% | 1278 |
|
2022
Q3 | $256K | Buy |
61,775
+10,736
| +21% | +$44.5K | 0.01% | 1343 |
|
2022
Q2 | $205K | Buy |
+51,039
| New | +$205K | 0.01% | 1368 |
|
2022
Q1 | – | Sell |
-40,987
| Closed | -$286K | – | 1839 |
|
2021
Q4 | $286K | Sell |
40,987
-53,725
| -57% | -$375K | ﹤0.01% | 1349 |
|
2021
Q3 | $947K | Buy |
+94,712
| New | +$947K | 0.02% | 887 |
|
2016
Q1 | – | Sell |
-12,700
| Closed | -$119K | – | 1652 |
|
2015
Q4 | $119K | Buy |
+12,700
| New | +$119K | ﹤0.01% | 1362 |
|
2015
Q3 | – | Sell |
-17,663
| Closed | -$371K | – | 1616 |
|
2015
Q2 | $371K | Buy |
+17,663
| New | +$371K | 0.01% | 937 |
|